These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17518169)

  • 21. Novel pharmacological approaches for the antagonism of neuromuscular blockade.
    Pic LC
    AANA J; 2005 Feb; 73(1):37-40. PubMed ID: 15727282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cyclodextrin. A new concept for antagonizing muscle relaxants].
    Sparr HJ
    Anaesthesist; 2002 Nov; 51(11):929-30. PubMed ID: 12434269
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients.
    Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK
    Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversal of prolonged rocuronium neuromuscular blockade with sugammadex in an obstetric patient with transverse myelitis.
    Weekes G; Hayes N; Bowen M
    Int J Obstet Anesth; 2010 Jul; 19(3):333-6. PubMed ID: 20627694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Mercer SJ; Moneypenny MJ
    Anaesthesia; 2011 Mar; 66(3):223-4. PubMed ID: 21320093
    [No Abstract]   [Full Text] [Related]  

  • 26. Reversal of rocuronium-induced (1.2 mg/kg) profound neuromuscular block by sugammadex: a multicenter, dose-finding and safety study.
    de Boer HD; Driessen JJ; Marcus MA; Kerkkamp H; Heeringa M; Klimek M
    Anesthesiology; 2007 Aug; 107(2):239-44. PubMed ID: 17667567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 28. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 30. First human exposure to Org 25969.
    Nigrovic V; Bhatt SB; Amann A
    Anesthesiology; 2006 Aug; 105(2):427; author reply 427. PubMed ID: 16871080
    [No Abstract]   [Full Text] [Related]  

  • 31. Sugammadex: a novel approach to reversal of neuromuscular blockade.
    Aniskevich S; Leone BJ; Brull SJ
    Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suspicion of duplicate publication regarding "J Anesth 2011; 25:953-4".
    Hirota K
    J Anesth; 2012 Apr; 26(2):320. PubMed ID: 22391669
    [No Abstract]   [Full Text] [Related]  

  • 33. The use of rocuronium and sugammadex in paediatric renal transplantation: Two case reports.
    Carlos RV; Torres ML; de Boer HD
    Eur J Anaesthesiol; 2016 May; 33(5):383-6. PubMed ID: 26351827
    [No Abstract]   [Full Text] [Related]  

  • 34. Sugammadex in clinical practice.
    Mirakhur RK
    Anaesthesia; 2009 Mar; 64 Suppl 1():45-54. PubMed ID: 19222431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sugammadex: a novel neuromuscular blocker binding agent.
    Fields AM; Vadivelu N
    Curr Opin Anaesthesiol; 2007 Aug; 20(4):307-10. PubMed ID: 17620836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 37. [A case of rocuronium-induced anaphylactic shock, improved by sugammadex].
    Badaoui R; Popov I; Dupont H
    Can J Anaesth; 2012 Sep; 59(9):909-10. PubMed ID: 22653841
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of Alzheimer's disease medication on muscle relaxants.
    Russell WJ
    Anaesth Intensive Care; 2009 Jan; 37(1):134-5. PubMed ID: 19160552
    [No Abstract]   [Full Text] [Related]  

  • 39. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist.
    Hemmerling TM; Zaouter C; Geldner G; Nauheimer D
    Ann Card Anaesth; 2010; 13(3):206-16. PubMed ID: 20826961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sugammadex in rocuronium anaphylaxis: dose matters.
    Barthel F; Stojeba N; Lyons G; Biermann C; Diemunsch P
    Br J Anaesth; 2012 Oct; 109(4):646-7. PubMed ID: 22976863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.